Monogenic migraine syndromes highlight novel drug targets

Drug Development Research

Volumn 68, Issue 7, 2007, Pages 432-440

  Gargus, J Jay ^a   Shih, Cindy H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C. Elegans; Channelopathy; Epilepsy; Ion channel; K ATPase; Na

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTICONVULSIVE AGENT; BOTULINUM TOXIN; CALCIUM CHANNEL; SODIUM CHANNEL; TRIPTAN DERIVATIVE;

CACNA1A GENE; CAENORHABDITIS ELEGANS; DRUG RESEARCH; FAMILIAL HEMIPLEGIC MIGRAINE; GENE; GENE MUTATION; HUMAN; MIGRAINE; MISSENSE MUTATION; MONOGENIC DISORDER; NONHUMAN; PATHOGENESIS; REVIEW; SEIZURE; SYNDROME;

EID: 38849099779     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20212     Document Type: Review

References (66)

1. 2+ channel alpha1A subunit and SNAP-25 in round or neurite-emitting chromaffin cells. Eur J Neurosci 22:2187-2198.
2. Barrett CF, Cao YQ, Tsien RW. 2005. Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel. J Biol Chem 280:24064-24071.
3. Blostein R, Segall L, Scanzano R, Mezzetti A, Purisima E, Gargus JJ. 2005. Functional alterations in the α2 isoform of the Na,K-ATPase associated with familial hemiplegic migraine type 2. Invited paper. J Gen Physiol 126:5a-6a.
4. Blostein R, Segal L, Gargus JJ. 2006. ATP1A2: un facteur essentiel dans la migraine hémiplégique familiale. Med Sci (Paris) 22:341-343.
5. Brusco A, Gellera C, Cagnoli C, Saluto A, Castucci A, Michielotto C, Fetoni V, Mariotti C, Migone N, Di Donato S, Taroni F. 2004. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 61:727-733.
6. lh) and tottering (Cacnalatg) mouse thalami. J Neurophysiol 81:2066-2074.
7. 2+ channel activity and inhibitory synaptic transmission. Proc Natl Acad Sci USA 102:2590-2595.
8. +-ATPase gene mutations. Neuromol Med 6:105-116.
9. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. 2004. Mapping complex disease loci in whole-genome association studies. Nature 429:446-452.
10. Ceulemans BP, Claes LR, Lagae LG. 2004. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy. Pediatr Neurol 30:236-243.
11. Davis MW, Somerville D, Lee RY, Lockery S, Avery L, Fambrough DM. 1995. Mutations in the Na,K-ATPase alpha-subunit gene, eat-6, disrupt excitable cell function. J Neurosci 15:8408-8418.
12. +-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43:169-175.
13. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192-196.
14. Dempsey CM, Mackenzie SM, Gargus A, Blanco G, Sze JY. 2005. Serotonin (5HT), fluoxetine, imipramine and dopamine target distinct 5HT receptor signaling to modulate Caenorhabditis elegans egg-laying behavior. Genetics 169:1425-14236.
15. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, Ferrari MD, Herzog J, van den Maagdenberg AM, Pusch M, Strom TM. 2005. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371-377.
16. 4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 66:1531-1539.
17. Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, An-Gourfinkel I, Brice A, LeGuern E, Moulard B, Chaigne D, Buresi C, Malafosse A. 2000b. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 24:343-345.
18. Gargus JJ. 2003. Unraveling monogenic channelopathies and their implications for complex polygenic disease. Am J Hum Genet72:785-803.
19. Gargus JJ. 2005. Receptor, transporter and ion channel diseases. In: Meyers RA, editors. Encyclopedia of molecular cell biology and molecular medicine. Vol 11. Weinheim: Wiley-VCH Verlag GmbH. p 637-711.
20. Gargus JJ. 2006. Ion channel functional candidate genes in multigenic neuropsychiatric disease. Biol Psychiatry 60:177-185.
21. Gargus JJ, Tournay A. 2007. Novel mutation confirms seizure locus SCN1A is also FHM3 migraine locus. Pediatr Neurol (in press).
22. 2+ signaling. Am J Physiol Cell Physiol 284:C475-486.
23. Hartford AK, Messer ML, Moseley AE, Lingrel JB, Delamere NA. 2004. Na,K-ATPase alpha 2 inhibition alters calcium responses in optic nerve astrocytes. Glia 45:229-237.
24. Hunter DJ, Kraft P. 2007.Drinking from the fire hose - statistical issues in genome wide association studies. N Engl J Med 357:436-439.
25. Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calandriello L, Francia A, Spadaro M, Pierelli F, Salvi F, Ophoff RA, Frants RR, Frontali M. 1997. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene of chromosome 19p. Hum Mol Genet 6:1973-1978.
26. Jones AK, Buckingham SD, Sattelle DB. 2005. Chemistry-to-gene screens in Caenorhabditis elegans. Nat Rev Drug Discov 4:321-330.
27. Jorgensen PL, Hakansson KO, Karlish SJ. 2003. Structure and mechanism of Na,K-ATPase: functional sites and their interactions. Annu Rev Physiol 65:817-849.
28. + pump alpha subunit isoforms in plasmalemma. Physiological implications. Ann NY Acad Sci 834:524-536.
29. Kaja S, van de Ven RC, Broos LA, Veldman H, van Dijk JG, Verschuuren JJ, Frants RR, Ferrari MD, van den Maagdenberg AM, Plomp JJ. 2005. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135:81-95.
30. Kaletta T, Hengartner MO. 2006. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov 5:387-398.
31. Kaplan JH. 2002. Biochemistry of Na,K-ATPase. Annu Rev Biochem 71:511-535.
32. Kaplan JH. 2005. The sodium pump and hypertension: a physiological role for the cardiac glycoside binding site of the Na,K-ATPase. Proc Natl Acad Sci USA 102:15723-157154.
33. Kaunisto MA, Harno H, Vanmolkot KR, Gargus JJ, Sun G, Hamalainen E, Liukkonen E, Kallela M, van den Maagdenberg AM, Frants RR, Farkkila M, Palotie A, Wessman M. 2004. A novel missense ATP1A2 mutation in a Finnish family with familial hemiplegic migraine type 2. Neurogenetics 5:141-146.
34. Kors EE, Melberg A, Vanmolkot KR, Kumlien E, Haan J, Raininko R, Flink R, Ginjaar HB, Frants RR, Ferrari MD, and van den Maagdenberg AM. 2004. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63:1136-1137.
35. Lencesova L, O'Neill A, Resneck WG, Bloch RJ, Blaustein MP. 2004. Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. J Biol Chem 279:2885-2893.
36. Ma S, Gargus JJ. 2007a. The genetics of neuronal channelopathies. In: Encyclopedia of life sciences. Chichester: John Wiley & Sons.
37. Ma S, Gargus JJ. 2007b. Functional analysis of familial hemiplegic migraine loci in C. elegans. Abstract 324A. In: 16th International C. elegans meeting, Los Angeles, CA.
38. Mathews EA, Garcia E, Santi CM, Mullen GP, Thacker C, Moerman DG, Snutch TP. 2003. Critical residues of the Caenorhabditis elegans unc-2 voltage-gated calcium channel that affect behavioral and physiological properties. J Neurosci 23:6537-6545.
39. Meisler MH, Kearney J, Ottman R, Escayg A. 2001. Identification of epilepsy genes in human and mouse. Annu Rev Genet 35:567-588.
40. Miyakawa-Naito A, Uhlen P, Lal M, Aizman O, Mikoshiba K, Brismar H, Zelenin S, Aperia A. 2003. Cell signaling microdomain with Na,K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations. J Biol Chem 278:50355-50361.
41. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H, Bennett V. 2003. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421:634-429.
42. Mohler PJ, Davis JQ, Bennett V. 2005. Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain. PLoS Biol 3:e423-429.
43. Monnier N, Procaccio V, Stieglitz P, Lunardi J. 1997. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha-1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 60:1316-1325.
44. Moskowitz MA, Bolay H, Dalkara T. 2004. Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol 55:276-280.
45. 2+ channel gene CACNL1A4. Cell 87:543-552.
46. Pietrobon D. 2005. Migraine: new molecular mechanisms. Neuroscientist 11:373-386.
47. 2+ channels. Cell 102:89-97.
48. Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, Santiago L, Moore M, Fouad G, Bradley P, Leppert MF. 1994. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863-868.
49. Ropers HH. 2007. New perspectives for the elucidation of genetic disorders. Am J Hum Genet 81:199-207.
50. Sakaba T, Stein A, Jahn R, Neher E. 2005. Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage. Science 309:491-494.
51. Schafer WR, Kenyon CJ. 1995. A calcium-channel homologue required for adaptation to dopamine and serotonin in Caenorhabditis elegans. Nature 375:73-78.
52. Segall L, Scanzano R, Kaunisto MA, Wessman M, Palotie A, Gargus JJ, Blostein R. 2004. Kinetic alterations due to a missense mutation in the Na,K-ATPase α2 subunit cause familial hemiplegic migraine type 2. J Biol Chem 279:43692-43696.
53. Segall L, Mezzetti A, Scanzano R, Gargus JJ, Purisima E, Blostein R. 2005. Alterations in the α2 isoform of the Na,K-ATPase associated with familial hemiplegic migraine type 2. Proc Natl Acad Sci USA 102:11106-11111.
54. Sieburth D, Ch'ng Q, Dybbs M, Tavazoie M, Kennedy S, Wang D, Dupuy D, Rual JF, Hill DE, Vidal M, Ruvkun G, Kaplan JM. 2005. Systematic analysis of genes required for synapse structure and function. Nature 436:510-527.
55. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT. 2004. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119:19-31.
56. Splawski I, Yoo DS, Stotz SC, Cherry A, Clapham DE, Keating MT. 2006. CACNA1H mutations in autism spectrum disorders. J Biol Chem 281:22085-22091.
57. Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BHF, Wutz K, Gutwillinger N, Ruther K, Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A, Meindl A. 1998. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 19:260-263.
58. Sugawara T, Mazaki-Miyazaki E, Fukushima K, Shimomura J, Fujiwara T, Hamano S, Inoue Y, Yamakawa K. 2002. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 58:1122-1124.
59. 2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci USA 99:13284-13289.
60. +-ATPase of the sarcoplasmic reticulum. Annu Rev Biochem 73:269-292.
61. Toyoshima C, Mizutani T. 2004. Crystal structure of the calcium pump with a bound ATP analogue. Nature 430:529-535.
62. Valentine JS, Doucette PA, Zittin PS. 2004. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563-593.
63. Weiss LA, Escayg A, Kearney JA, Trudeau M, MacDonald BT, Mori M, Reichert J, Buxbaum JD, Meisler MH. 2003. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry 8:186-194.
64. Wessman M, Terwindt GM, Kaunisto MA, Palotie A, Ophoff RA. 2007. Migraine: a complex genetic disorder. Lancet Neurol 6:521-532.
65. Yue Q, Jen JC, Nelson SF, Baloh RW. 1997. Progressive ataxia due to a missense mutation in a calcium-channel gene. Am J Hum Genet 61:1078-1087.
66. 1A-voltage-dependent calcium channel. Nat Genet 15:62-69.